NEDD4L inhibits cell viability, cell cycle progression, and glutamine metabolism in ESCC by ubiquitination of c-Myc to decrease the expressions of GLS1 and SLC1A5. This evidence concerns the gene SLC1A5 and esophageal squamous cell carcinoma.